The use of biomarkers to characterize colorectal cancer: From genetic make-up to complex phenotypic measurement

Journal of Molecular Biomarkers & Diagnosis

ISSN: 2155-9929

Open Access

The use of biomarkers to characterize colorectal cancer: From genetic make-up to complex phenotypic measurement

5th International Conference on Biomarkers & Clinical Research

April 15-17, 2014 St. Hilda’s College - University of Oxford, UK

P. Vodicka, J. Slyskova, B. Pardini, A. Naccarati, L. Vodickova, L. Bielik, V. Polakova, P. Prochazka, M. Svoboda, M. Burocziova, P. Soucek, J. Hesketh, S. Landi, R. Kumar, F. Canzian, A. Foersti and K. Hemmiki

Scientific Tracks Abstracts: J Mol Biomark Diagn

Abstract :

M ajority of cancer cases occurs sporadically as a consequence of complex interplay between genetic variants and environmental factors. Colorectal carcinogenesis (CRC) involves a plethora of events, such as uncontrolled proliferation and genomic instability, which point to the DNA repair and DNA damage response as to the key players. Here we overview several biomarkers in mapping heterogenous complex disease, which poses a serious health problem worldwide, and provide an excursion into the DNA repair phenotypic reflection in control individuals and CRC patients. Gene variants involved in pathways, such as DNA repair, cell cycle control, folate metabolism and methylation, insulin resistance and obesity, ABC transporters, seleno proteins, inflammatory/immune response have shown various degree of association with CRC risk. Gene expression levels in relevant pathways were complemented with transcription regulations by methylation. Post-transcriptional regulation via miRNA or lncRNA was evaluated in relation to the CRC risk and the efficacy of chemotherapy. SNPs in miRNA binding sites of SMUG1 gene affect significantly survival in 5-fluorouracil-treated CRC patients, suggesting the importance of SNPs within miRNA-dependent regulatory regions. Expressions of the specific proteins (mismatch repair, base excision repair) were also assayed for. Functional DNA repair tests have been implemented as biomarkers of the complex phenotype. Multiple biomarkers, covering genetic, epigenetic and functional aspects, may define the phenotypic landscape of the disease and delineate the individual response to the therapy. Functional DNA repair assays reflect the capacity of the organism to cope with a chronic exposure to numerous environmental and dietary genotoxicants and may also be used as predictive markers in cancer therapy

Biography :

Pavel Vodicka graduated at the Medical Faculty, Charles University, Prague and in 1986 obtained Ph.D. in biochemistry. He worked as postdoctoral fellow at the Finnish Inst. Occupat. Health, Helsinki, Finland (1987-1990) and as visiting scientist at Karolinska Institute, Huddinge, Sweden (1990-1993). Since 2002 he heads the Dept. Molec. Biol. Cancer, Inst. Exper. Medicine, Acad. Sci., Prague, Czech Republic. Pavel Vodicka has published more than 130 (total IF 552.4, 2650 citations a HI 31) articles. Since 2004, his main research topics are focused on the DNA and chromosomal damage and DNA repair functional tests in humans and on transient biomarkers in the onset of gastrointestinal cancers. In 2012 he edited the Special Issue in Mutagenesis ( toc), entitled Colorectal Cancer-Current Insights into Susceptibility.

Google Scholar citation report
Citations: 2054

Journal of Molecular Biomarkers & Diagnosis received 2054 citations as per Google Scholar report

Journal of Molecular Biomarkers & Diagnosis peer review process verified at publons

Indexed In

arrow_upward arrow_upward